JPMorgan Chase & Co’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,999
| Closed | -$141K | – | 6802 |
|
|
2023
Q4 | $141K | Buy |
13,999
+1,161
| +9% | +$11.7K | ﹤0.01% | 4625 |
|
|
2023
Q3 | $37K | Buy |
12,838
+10,573
| +467% | +$30.5K | ﹤0.01% | 4992 |
|
|
2023
Q2 | $8.63K | Buy |
2,265
+62
| +3% | +$236 | ﹤0.01% | 5191 |
|
|
2023
Q1 | $4K | Buy |
2,203
+178
| +9% | +$323 | ﹤0.01% | 5454 |
|
|
2022
Q4 | $5K | Sell |
2,025
-1,249
| -38% | -$3.08K | ﹤0.01% | 5237 |
|
|
2022
Q3 | $11K | Buy |
3,274
+425
| +15% | +$1.43K | ﹤0.01% | 5056 |
|
|
2022
Q2 | $16K | Sell |
2,849
-3,212
| -53% | -$18K | ﹤0.01% | 5099 |
|
|
2022
Q1 | $14K | Buy |
6,061
+1,649
| +37% | +$3.81K | ﹤0.01% | 5334 |
|
|
2021
Q4 | $27K | Buy |
4,412
+4,331
| +5,347% | +$26.5K | ﹤0.01% | 5256 |
|
|
2021
Q3 | $1K | Buy |
+81
| New | +$1K | ﹤0.01% | 5470 |
|